Sponsorship of Canadian Professional Medical Societies by Drug, Medical Device and Medical Technology Companies: a Cross-sectional Study-Reference-Cited by-同舟云学术

Sponsorship of Canadian Professional Medical Societies by Drug, Medical Device and Medical Technology Companies: a Cross-sectional Study

Published:2022-04-27 Issue:16 Volume:37 Page:4280-4282
ISSN:0884-8734
Container-title:Journal of General Internal Medicine
language:en
Short-container-title:J GEN INTERN MED

Author:

Lexchin Joel^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11606-022-07623-0.pdf

Reference7 articles.

1. Jatoi I, Shah S. Clinical practice guidelines and the overuse of health care services: need for reform. CMAJ. 2019;191:E297-8. https://doi.org/10.1503/cmaj.181496.

2. Steinbrook R. Haemoglobin concentrations in chronic kidney disease. Lancet. 2006;368:2191-3.

3. Rothman D, McDonald W, Berkowitz C, Chimonas S, DeAngelis C, Hale R, et al. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA. 2009;301:1367-72.

4. Royal College of Physicians and Surgeons of Canada. National specialty societies. 2022. https://www.royalcollege.ca/rcsite/resources/national-specialty-societies-e. Accessed 8 Jan 2022.

5. Shnier A, Lexchin J. Continuing medical education and pharmaceutical industry involvement: an evaluation of policies adopted by Canadian professional medical associations. International Journal of Risk & Safety in Medicine. 2017;29:1-16. https://doi.org/10.3233/JRS-170731.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sponsorship of Australian and New Zealand medical societies by healthcare companies: an observational study;JRSM Open;2022-07